Adeno-associated viral vectors and their redirection to cell-type specific receptors.
about
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidateStructure of neurotropic adeno-associated virus AAVrh.8.Micrornas in prostate cancer: an overview.miR-26a is required for skeletal muscle differentiation and regeneration in mice.Combinatorial peptide libraries: mining for cell-binding peptides.A capillary electrophoresis sequencing method for the identification of mutations in the inverted terminal repeats of adeno-associated virusBinding site on the transferrin receptor for the parvovirus capsid and effects of altered affinity on cell uptake and infection.Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivoTargeting microRNAs in cancer: rationale, strategies and challenges.RNAi and small interfering RNAs in human disease therapeutic applications.Recombinant AAV-directed gene therapy for type I glycogen storage diseases.Targeting neurons of rat nucleus tractus solitarii with the gene transfer vector adeno-associated virus type 2 to up-regulate neuronal nitric oxide synthase.Novel cytotoxic vectors based on adeno-associated virus.MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals.Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors.Biomathematical description of synthetic peptide libraries.Therapeutic Opportunities for Targeting microRNAs in Cancer.The AAV vector toolkit: poised at the clinical crossroadsExamining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5.Advances in cell and gene-based therapies for cystic fibrosis lung diseaseThe threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.Gene therapy for radioprotection.Ribosomal DNA integrating rAAV-rDNA vectors allow for stable transgene expression.A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotypeEvolutionary reversion of live viral vaccines: Can genetic engineering subdue it?Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs.Strategies for targeting primate neural circuits with viral vectors.The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia.Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure.Treatment of diabetes with glucagon-like peptide-1 gene therapy.Adeno-associated viral vectors for mapping, monitoring, and manipulating neural circuits.Targeted gene therapy for the treatment of heart failure.Viral vectors for gene delivery to the central nervous system.Cocaine hydrolase gene therapy for cocaine abuseRNAi-mediated gene silencing in cancer therapy.MicroRNAs in brain metastases: potential role as diagnostics and therapeutics.Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.Current and future prospects for hemophilia gene therapy.
P2860
Q24288709-292E3A91-900C-4F9F-8D92-444494AE489DQ30152836-EB909C3F-0A63-4294-9A8C-66A7FD189A9FQ30234658-2ED82BDC-5F38-47F1-BD0E-24BAB73DF6BCQ30421569-772ACD13-4513-4D1D-86F1-93F8356EC1BDQ31144876-835C1035-605A-46CF-BBA6-A06431F0A4F7Q33586945-DA5BF040-5824-48A9-90D3-C9D4DCD21F4FQ33826804-EA2079AF-3253-4FBC-B1D1-588DB4D3753BQ33833473-7862C084-7DBB-4989-BACF-9971F815C829Q33995646-9BAA8934-3CA0-444A-9DE6-646D1730D5E7Q34141089-CAA29185-8593-4AC1-AF30-51BAAC3846BCQ34204092-7FAE65FF-3702-4921-911A-973F99EE3DD1Q35078590-102BC64F-FB1D-4B69-A9B4-022C53BCEF11Q35136635-6D0E0629-FBAD-4594-9776-FC7E1EB8C0AFQ35155679-54ED3B2E-F81F-4D25-B8C3-E9B717D6D7D2Q35388050-A332C9D0-4538-4C0F-AE3A-B107C659165DQ35649591-57F12CC0-8808-4D8E-A4D5-DA9993FD84E8Q35652428-BE00DB47-BCE9-4857-9835-15D59838DD80Q35673914-214EC6E7-2F40-4FA7-AFEC-BA942056C2F5Q35876224-4EBFEBBE-E75D-4064-AB56-CE995BB84F46Q35960506-D9CF50C5-35F6-4A5C-8864-FF7947C51961Q36014033-0B41CF59-9454-46E8-BF21-F7A54693D058Q36155013-C7ECAAEB-9978-411E-BFE9-E6F61D1CEF55Q36170038-6EBF389B-0D85-44DC-B7AA-8980C6933911Q36298655-D07CED0B-A127-4F34-8995-9EF316D528E2Q36715338-1E91CCCE-6B6B-436E-992F-E1BA8C8DF59FQ36738542-84986DAC-069D-4133-A8ED-B4AD5EF7A89CQ37082190-409C566A-F04F-4FDA-AD72-A3F4AC1F2394Q37118845-89522FCE-C7E4-4002-919D-BE4063A501ACQ37127728-546FE8B9-2872-4316-9CF6-6AE34941DAE3Q37503995-32F11FD9-07F6-4F89-BDD8-C9FE21931472Q37685861-10B3490E-570F-4100-9DA8-9988764D5FB5Q37804398-A17C428B-FD69-4E0B-9A86-2E0FD18649FAQ37841584-E37D7241-AC2D-4BDF-AB6E-6BC6B15C9C9DQ37878086-E300CA38-3FEC-44EA-86BA-1CF8E03AB5EAQ37946113-BEB65841-388F-455D-A204-7AD2E78D514CQ37980864-9CF90F32-8A73-417E-AB76-9910D9E5FAA4Q38030982-10EA3AFE-DB38-4095-9353-AE9A8298B9C3Q38219675-80018768-5A13-400D-B5A6-38818D0BC81AQ38257397-262D861C-D6D7-461A-AA67-0FC697B3CC43Q38827606-DD3C36DD-AFC9-4CEF-BC2E-613ED3C977D6
P2860
Adeno-associated viral vectors and their redirection to cell-type specific receptors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Adeno-associated viral vectors and their redirection to cell-type specific receptors.
@ast
Adeno-associated viral vectors and their redirection to cell-type specific receptors.
@en
type
label
Adeno-associated viral vectors and their redirection to cell-type specific receptors.
@ast
Adeno-associated viral vectors and their redirection to cell-type specific receptors.
@en
prefLabel
Adeno-associated viral vectors and their redirection to cell-type specific receptors.
@ast
Adeno-associated viral vectors and their redirection to cell-type specific receptors.
@en
P1433
P1476
Adeno-associated viral vectors and their redirection to cell-type specific receptors.
@en
P2093
Martin Trepel
Stefan Michelfelder
P356
10.1016/S0065-2660(09)67002-4
P577
2009-01-01T00:00:00Z